NCT07881601
Effects of Ubiquinol and Ubiquinone on Vascular Function in Healthy Adults With Borderline High LDL-Cholesterol
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Enrolling by invitation only
- Start date pushed from Oct 17, 2026 to Nov 4, 2026
- Primary completion date: Dec 19, 2026 to Jan 8, 2027
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (9)
Show 4 moreShow less
Arms and interventions
Participants will receive Ubiquinol 200 mg/day, administered orally as two soft capsules once daily for 8 weeks. Participants will be instructed to take the capsules with water or warm water after breakfast or lunch containing fat.
Participants will receive Ubiquinone 200 mg/day, administered orally as two soft capsules once daily for 8 weeks. Participants will be instructed to take the capsules with water or warm water after breakfast or lunch containing fat.
Participants will receive identical placebo soft capsules orally as two capsules once daily for 8 weeks, according to the study randomization schedule.
Dietary supplements: Ubiquinol, Ubiquinone
Other: Placebo
Sites
1 site in 1 country
- San Francisco Research InstituteSan Francisco, California, United States